raloxifene has been researched along with y134 compound in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, B; Wang, M; Wu, X; Xie, Y; Xu, G; Yan, X; Yang, C | 1 |
| Dadiboyena, S | 1 |
1 review(s) available for raloxifene and y134 compound
| Article | Year |
|---|---|
Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.
Topics: Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Isotope Labeling; Organometallic Compounds; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2012 |
1 other study(ies) available for raloxifene and y134 compound
| Article | Year |
|---|---|
Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
Topics: Animals; Binding, Competitive; Bone Density; Drug Evaluation, Preclinical; Estrogen Receptor alpha; Female; Ligands; Mice; Molecular Structure; Piperazines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Thiophenes; Uterus | 2005 |